STML - Stemline Therapeutics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2018)Next Qtr. (Sep 2018)Current Year (2018)Next Year (2019)
No. of Analysts4444
Avg. Estimate-0.65-0.67-2.76-0.5
Low Estimate-0.69-0.74-2.92-1.76
High Estimate-0.6-0.61-2.521.54
Year Ago EPS-0.66-0.68-2.94-2.76
Revenue EstimateCurrent Qtr. (Jun 2018)Next Qtr. (Sep 2018)Current Year (2018)Next Year (2019)
No. of Analysts4444
Avg. Estimate50k50k630k75.22M
Low EstimateN/AN/AN/A21.93M
High Estimate200k200k2.5M135M
Year Ago Sales299k299k898k630k
Sales Growth (year/est)-83.30%-83.30%-29.80%11,839.70%
Earnings History6/29/20179/29/201712/30/20173/30/2018
EPS Est.-0.48-0.59-0.7-0.69
EPS Actual-0.66-0.68-0.93-0.69
Difference-0.18-0.09-0.230
Surprise %-37.50%-15.30%-32.90%0.00%
EPS TrendCurrent Qtr. (Jun 2018)Next Qtr. (Sep 2018)Current Year (2018)Next Year (2019)
Current Estimate-0.65-0.67-2.76-0.5
7 Days Ago-0.65-0.68-2.76-0.12
30 Days Ago-0.68-0.7-2.82-0.19
60 Days Ago-0.64-0.65-2.31.05
90 Days Ago-0.58-0.5-1.761.06
EPS RevisionsCurrent Qtr. (Jun 2018)Next Qtr. (Sep 2018)Current Year (2018)Next Year (2019)
Up Last 7 Days111N/A
Up Last 30 Days2221
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/A1
Growth EstimatesSTMLIndustrySectorS&P 500
Current Qtr.1.50%N/AN/A0.43
Next Qtr.1.50%N/AN/A0.45
Current Year6.10%N/AN/A0.21
Next Year81.90%N/AN/A0.10
Next 5 Years (per annum)N/AN/AN/A0.11
Past 5 Years (per annum)N/AN/AN/AN/A